Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s11684-018-0658-4
Published Online: 2019-06-11
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Xiaoxiao
Tang, Yanjing
Chen, Jing
Chen, Ru
Gu, Longjun
Xue, Huiliang
Pan, Ci
Tang, Jingyan
Shen, Shuhong
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
Received: 28 October 2017
Accepted: 15 June 2018
First Online: 11 June 2019